Valuation: DiaSorin S.p.A.

Market Cap 3.99B 4.45B 3.68B 3.33B 6.23B 424B 6.33B 43.91B 17.52B 222B 16.72B 16.36B 703B P/E 2026 *
24.4x
P/E 2027 * 20.8x
Enterprise Value 4.68B 5.23B 4.32B 3.91B 7.31B 498B 7.43B 51.55B 20.57B 261B 19.63B 19.21B 825B EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.45x
Free-Float
37.17%
Yield 2026 *
1.61%
Yield 2027 * 1.68%
1 day+0.50%
1 week+1.61%
Current month+5.47%
1 month+5.47%
3 months+17.46%
6 months+39.61%
Current year+18.04%
1 week 78.72
Extreme 78.72
81.98
1 month 72.8
Extreme 72.8
82.3
Current year 52.34
Extreme 52.34
82.3
1 year 52.34
Extreme 52.34
82.3
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
204.4
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/3/26 Buy

Chief Executive Officer

9,211 0.0165%
28/1/26 Buy

Chief Executive Officer

7,500 0.0134%
8/1/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+1.61%+6.13%-1.32% 4.45B
+1.88%+2.01%-15.96%+12.62% 181B
+2.55%+1.52%-15.65%+19.03% 120B
+2.46%+0.54%+5.87%+39.87% 119B
+0.11%-1.57%-44.18%+5.98% 91.44B
+1.91%-2.35%-0.79%+76.15% 63.07B
-0.46%+0.42%+8.19%+82.97% 55.8B
+1.63%-1.04%+9.27%-21.17% 54.03B
+2.32%+1.63%-8.23%+47.17% 45.38B
+0.02%+1.59%-1.11%-6.94% 34.37B
Average +1.07%+0.55%-5.65%+25.44% 76.79B
Weighted average by Cap. +1.24%+0.76%-9.87%+26.08%

Financials

2026 *2027 *
Net sales 1.24B 1.38B 1.14B 1.03B 1.93B 131B 1.96B 13.61B 5.43B 68.81B 5.18B 5.07B 218B 1.32B 1.47B 1.21B 1.1B 2.06B 140B 2.09B 14.49B 5.78B 73.25B 5.52B 5.4B 232B
Net income 181M 202M 167M 151M 283M 19.26B 287M 1.99B 795M 10.08B 759M 743M 31.92B 205M 228M 189M 171M 319M 21.75B 324M 2.25B 898M 11.38B 857M 839M 36.05B
Net Debt 694M 775M 641M 580M 1.08B 73.82B 1.1B 7.64B 3.05B 38.63B 2.91B 2.85B 122B 556M 620M 513M 464M 867M 59.06B 881M 6.11B 2.44B 30.91B 2.33B 2.28B 97.9B
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
30/10/26 EUR 80.92 +0.40% 2,528
29/10/26 EUR 80.60 -1.42% 115,226
28/10/26 EUR 81.76 +1.31% 119,964
27/10/26 EUR 80.70 -0.25% 112,380
26/10/26 EUR 80.90 +1.48% 95,328
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
80.60EUR
Average target price
76.38EUR
Spread / Average Target
-5.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.